Cherry Hill: Daughter’s opioid death caused by ‘corporate greed’
U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc., which made the powerful opioid believed to have played a role in the death of 32-year-old Sarah Fuller in Camden County last year.
Her mother, Deborah, described listening to an audio recording in which a drug company representative falsely said she was from Sarah’s doctor’s office and misled a pharmacy benefits manager into believing that Sarah had breakthrough cancer pain. That’s the only condition that Insys’ fast-acting fentanyl brand, Subsys, was approved to treat.
GET THE HELP YOU DESERVE
$1.65 Million Settlement
A $4,500,000 jury trial verdict (Settled for $1.65 million while
$1.14 Million Settlement
A $1,140,000 total settlement from a doctor who had been overprescribing prescription painkillers and the dispensing pharmacy that led to the patient becoming addicted and subsequently dying from the prescription drugs.
$1.08 Million Settlement
A $1,075,000 settlement for a dram shop case against a bar/restaurant for over-serving a patron who ultimately got behind the wheel of a car intoxicated, seriously injuring our two clients who were passengers in the vehicle when the driver lost control of his car and crashed.
This website is for informational purposes only. Using this site or communicating with Richard J. Hollawell & Associates through this site does not form an attorney/client relationship. This site is legal advertising.